Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice

Current Topics in Microbiology and Immunology

Volumn 265, Issue , 2002, Pages 23-48

  Wang, J ^a   Asensio, V C ^a   Campbell, I L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANTIVIRAL ACTIVITY; BRAIN INJURY; BRAIN PROTECTION; CELL COMMUNICATION; CYTOKINE PRODUCTION; DISEASE MODEL; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; MEDIATOR; MOLECULAR GENETICS; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; REVIEW; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0036130574     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-09525-6_2     Document Type: Review

References (156)

1. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
2. Interleukin-6 in biology and medicine
3. Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration
4. IL-12 production by central nervous system microglia is inhibited by astrocytes
5. IL-6 deficiency leads to increased emotionality in mice: Evidence in transgenic mice carrying a null mutation for IL-6
6. Chemokines and their receptors in the CNS: Plurifunctional mediators in diverse states
7. C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes the recruitment of macrophages to the central nervous system
8. + T cells via CD40 ligand
9. Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression
10. The interferons: Mechanisms of action and clinical applications
11. The protective role of endogenous interferon in viral, bacterial, and protozoal infections
12. A new class of membrane-bound chemokine with a CX3 C motif
13. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro
14. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6
15. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat
16. Tumor necrosis factor in the pathogenesis of infectious diseases
17. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system
18. Encephalitis among Cree children in Northern Quebec
19. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
20. Neurologic disease induced in transgenic mice by the cerebral overexpression of interleukin 6
21. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie
22. Transgenic modeling of neuropsychiatric disorders
23. Structural and functional neuropathology in transgenic mice with CNS expression of IFN-α
24. Astrocyte-targeted expression of IFN-alpha 1 protects mice from acute ocular herpes simplex virus type 1 infection
25. Localization of metallothionein-I and-III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin-6
26. Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation
27. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: A study on IL-6-deficient mice
28. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cultures
29. Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons
30. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice
31. Reactive gliosis as a consequence of interleukin-6 expression in the brain. Studies in transgenic mice
32. Gliosis and neurodegeneration as a consequence of the cerebral expression of IL-3 in transgenic mice
33. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
34. Transforming growth factor-beta (TGF-beta)
35. Transgenic mice expressing antisense interleukin-3 RNA develop a B-cell lymphoproliferative syndrome or neurologic dysfunction
36. Targeted CNS expression of interferon-γ in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development
37. Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common b chain in transgenic mice
38. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
39. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
40. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia
41. Neuronal death in cytokine-activated primary human brain cell culture: Role of tumor necrosis factor-α
42. Interferon-γ expression disrupts lens and retinal differentiation in transgenic mice
43. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
44. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage
45. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
46. Inflammatory gene expression in cerebral ischemia and trauma
47. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-α
48. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level
49. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
50. TGF-beta I is an organizer of responses to neurodegeneration
51. Tumor necrosis factor α and lymphotoxin α are not required for the induction of acute experimental autoimmune encephalomyelitis
52. Regulation of macrophage activation by IL-3
53. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1
54. Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydrocephalus
55. Gene knock-out technology: A methodological overview for the interested novice
56. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections
57. Inflammation in traumatic brain injury: Role of cytokines and chemokines
58. CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROα) modulate Purkinje neuron activity in mouse cerebellum
59. Synchronous synthesis of α and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis
60. Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system
61. Chemokine expression in murine experimental allergic encephalomyelitis
62. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum
63. Cytokines in the brain during viral infection: Clues to HIV-associated dementia
64. Physiological and pathological roles of interleukin-6 in the central nervous system
65. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia
66. Transgenic expression of interleukin-6 in the central nervous system regulates brain metallothionein-I and-III expression in mice
67. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain
68. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma
69. Expression of chemokine receptors by subsets of neurons in the central nervous system
70. Primary demyelination in transgenic mice expressing IFN-γ
71. Immune response in mice that lack the interferon-γ receptor
72. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2
73. A protective role for IL-6 during early infection with Toxoplasma gondii
74. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
75. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
76. Chemokine regulation of experimental autoimmune encephalomyelitis: Temporal and spatial expression patterns govern disease pathogenesis
77. Identification and characterization of receptors for tumor necrosis factor-α in the brain
78. Impaired neuroglial activation in interleukin-6 deficient mice
79. Impaired immune and acute-phase responses in interleukin-6-deficient mice
80. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting
81. Interferon-gamma confers resistance to experiemental allergic encephalomyelitis
82. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF
83. Lethal tuberculosis in interleukin-6-deficient mutant mice
84. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy
85. Lymphokine induction of rat microglia multinucleated giant cell formation
86. Tumor necrosis factor α in cerebrospinal fluid during bacterial, but not viral, meningitis
87. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12
88. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus
89. AIDS-related dementia and calcium homeostasis
90. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
91. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat
92. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria
93. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
94. 3CR-1-expressing microglia
95. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice
96. Chemokines and chemokine receptors in the CNS: A possible role in neuroinflammation and patterning
97. Cytokines in inflammatory brain lesions: Helpful and harmful
98. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
99. Localization of fractalkine and CX3CR1 mRNAs in rat brain: Does fractalkine play a role in signaling from neuron to microglia?
100. Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells
101. Inflammatory cytokines in the brain: Does the CNS shape immune responses?
102. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis
103. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
104. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
105. Induction of IL-12 gene expression in the brain in septic shock
106. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor
107. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice
108. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact
109. Signaling pathways activated by interferons
110. Response of glia, mast cells and blood brain barrier, in transgenic mice expressing interleukin-3 in astrocytes, an experimental model for CNS demyelination
111. Chemokine receptors - Gateways to inflammation and infection
112. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α
113. Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice
114. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1
115. Multiple sclerosis: TNF revisited with promise
116. Chemokines in immune-mediated inflammation of the central nervous system
117. Interferon-γ in progression to chronic demyelination and neurological deficit following acute EAE
118. Inflammation and Alzheimer's disease pathogenesis
119. Cytokines and the nervous system II: Actions and mechanisms of action
120. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
121. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
122. Neuronal expression of fractalkine in the presence and absence of inflammation
123. Structure and chromosomal localization of the human stromal cell-derived factor I (SDF1) gene
124. Targeted disruption of the mouse transforming growth factor β1 gene results in multifocal inflammatory disease
125. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat
126. Increased interleukin-12 levels in human cerebrospinal fluid following severe head trauma
127. Lipopolysaccharide induced interleukin-12 expression in the CNS and cultured astrocytes and microglia
128. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor
129. Some misconceptions about understanding autoimmunity through experiments with knockouts
130. CNS interleukin-3 (IL-3) expression and neurological syndrome in anti-sense-IL-3 transgenic mice
131. Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis
132. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice
133. Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro
134. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
135. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes
136. Signal sequence trap: A cloning strategy for secreted proteins and type I membrane proteins
137. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system
138. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1α or its CCR5 receptor
139. Axonal transection in the lesions of multiple sclerosis
140. Interleukin-12 and interferon-γ
141. Regulation of the genes encoding interleukin-6, its receptor, and gp 130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β
142. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies
143. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis
144. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in Acquired Immune Deficiency Syndrome
145. Inflammatory and immunomodulatory roles of TGF-β
146. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12
147. The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis
148. Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field
149. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
150. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice
151. Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice
152. Chronic overproduction of transforming growth factor-beta 1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
153. Amyloidogenic role of cytokine TGF-beta 1 in transgenic mice and in Alzheimer's disease
154. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin
155. Chemokines: A new classification system and their role in immunity
156. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development